Page 6 - Bioscience Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioscience segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioscience Segment Today - Breaking & Trending Today

Grifols (NASDAQ:GRFS) Downgraded by StockNews.com

StockNews.com cut shares of Grifols (NASDAQ:GRFS – Get Rating) from a buy rating to a hold rating in a research note published on Monday morning. Other analysts also recently issued research reports about the stock. AlphaValue raised shares of Grifols to a buy rating in a research report on Monday, February 6th. Barclays raised shares […] ....

Jefferies Financial Group , First Trust Advisors , Morgan Stanley , Get Rating , Financial Group , Moderate Buy , World Investors , Trust Advisors , Investment Partners , State Street Corp , Street Corp , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs , Stocknews Com ,

Grifols (NASDAQ:GRFS) Rating Increased to Overweight at Morgan Stanley

Grifols (NASDAQ:GRFS – Get Rating) was upgraded by Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research note issued on Wednesday, The Fly reports. Several other brokerages have also recently commented on GRFS. AlphaValue upgraded Grifols to a “buy” rating in a report on Monday, February 6th. Barclays upgraded shares […] ....

Ronald Blue Trust Inc , Jefferies Financial Group , Quadrant Capital Group , Morgan Stanley , Brinker Capital Investments , Get Rating , Financial Group , Financial Advisors , Blue Trust , Capital Group , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs ,

Grifols, S.A. (NASDAQ:GRFS) Shares Sold by Lapides Asset Management LLC

Lapides Asset Management LLC lessened its position in shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) by 39.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 210,600 shares of the biotechnology company’s stock after selling 140,000 shares during the period. Lapides Asset Management […] ....

Morgan Stanley , Brinker Capital Investments , Jefferies Financial Group , Securities Exchange Commission , Lapides Asset Management , Ronald Blue Trust Inc , Financial Services Group Inc , Get Rating , Asset Management , Financial Advisors , Blue Trust , Capital Investments , Services Group , Financial Group , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

292,567 Shares in Grifols, S.A. (NASDAQ:GRFS) Acquired by International Assets Investment Management LLC

International Assets Investment Management LLC acquired a new stake in shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 292,567 shares of the biotechnology company’s stock, valued at approximately $5,694,000. Grifols makes up about 1.1% of International Assets Investment Management […] ....

Jefferies Financial Group , Morgan Stanley , International Assets Investment Management , Capital International Sarl , Financial Services Group Inc , Advisor Group Holdings Inc , Get Rating , Financial Advisors , Group Holdings , Services Group , International Sarl , Financial Group , Bio Supplies , Bioscience Segment , Hospital Segment , Visit Holdingschannel , Grifols Daily , Nasdaq Grfs , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Brokerages Set Grifols, S.A. (NASDAQ:GRFS) Price Target at $13.53

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) have received an average recommendation of “Moderate Buy” from the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price objective […] ....

Advisor Group Holdings Inc , Jefferies Financial Group , Quadrant Capital Group , Morgan Stanley , Get Rating , Marketbeat Ratings , Financial Group , Stock Down , Financial Advisors , Group Holdings , Capital Group , Creative Planning , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs ,